[Asia Economy Reporter Hwang Yoon-joo] Nexten announced on the 9th that it will acquire 1.98 million shares of NexID Lab, a subsidiary (planned) for discovering and evaluating domestic and international pharmaceutical bio ventures, for approximately 10 billion KRW.



After acquiring the shares, Nexten's stake in NexID Lab will be 100%. The scheduled date for the share acquisition is the same day as the announcement. Nexten stated that the purpose of this share acquisition is "entry into new business."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing